Small-cap stock under ₹50: Take Solutions’ share price would be in focus, as the company’s stock surged 150% in the past year, according to data from the National Stock Exchange ().
Take Solutions is a technology and consulting services provider in the life sciences and supply chain management sector. The company offers its solutions to assist entities in clinical research, compliance and regulatory affairs.
Shares of Take Solutions have delivered more than 69% return on investment in the last three years and 150% gains in the last one-year period, as per NSE data.
However, the data also showed that the company’s stock had lost 29.62% value over the last five years. But Take Solutions shares have risen 24.23% in the last one-month period. The small-cap company’s shares are trading 3.54% higher in the last five market sessions.
Take Solutions’ share price today
closed 1.15% higher at ₹40.40 in Thursday’s stock market session, compared to ₹39.94 at the previous market close, according to the NSE data.
Shares of Take Solutions reached their 52-week high of ₹41.20 on 31 December 2025, while the 52-week low stood at ₹6.51, according to exchange data.
The company’s market capitalisation (M-Cap) stood at ₹597.65 crore at market close on 1 January 2026, the first day of the new year.
Take Solutions’ plans ahead
In an exchange filing on 23 December 2025, Take Solutions announced that the company plans to build an advanced -driven diagnostic and preventive care platform to chart a long-term value roadmap in the healthcare sector.
“This planned platform represents TAKE Solution’s vision to shape the future of healthcare as India transitions from treatment-focused systems to AI-led early detection, predictive diagnostics, and preventive care,” the company said in an exchange filing.
On 31 December 2025, Take Solutions’ Whole-time director and Chief Financial Officer Vedamirtham Venkatesan submitted his , citing preoccupations and other personal commitments.
“This is to inform you that due to my pre-occupations and other personal commitments, I hereby tender my resignation from the position of Whole Time Director (Executive Capacity) and Chief Financial Officer of the Company with immediate effect,” said Vedamirtham Venkatesan in his letter to the board.
Along with Vedamirtham Venkatesan, the company director, Cecily Dheepa, also resigned on the same day, citing pre-occupations and other personal commitments. Both resignations took effect on 31 December 2025.
Read all stories by
Disclaimer: This story is for educational purposes only. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.